These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17229643)

  • 1. Idiotype protein vaccination in combination with adjuvant cytokines in patients with multiple myeloma--evaluation of T-cell responses by different read-out systems.
    Abdalla AO; Hansson L; Eriksson I; Näsman-Glaser B; Rossmann ED; Rabbani H; Mellstedt H; Osterborg A
    Haematologica; 2007 Jan; 92(1):110-4. PubMed ID: 17229643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients.
    Hansson L; Abdalla AO; Moshfegh A; Choudhury A; Rabbani H; Nilsson B; Osterborg A; Mellstedt H
    Clin Cancer Res; 2007 Mar; 13(5):1503-10. PubMed ID: 17332295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
    Stritzke J; Zunkel T; Steinmann J; Schmitz N; Uharek L; Zeis M
    Br J Haematol; 2003 Jan; 120(1):27-35. PubMed ID: 12492573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active idiotype vaccination in multiple myeloma. GM-CSF may be an important adjuvant cytokine.
    Mellstedt H; Osterborg A
    Pathol Biol (Paris); 1999 Feb; 47(2):211-5. PubMed ID: 10192891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.
    Abdalla AO; Hansson L; Eriksson I; Näsman-Glaser B; Mellstedt H; Osterborg A
    Eur J Haematol; 2007 Nov; 79(5):371-81. PubMed ID: 17916084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
    Titzer S; Christensen O; Manzke O; Tesch H; Wolf J; Emmerich B; Carsten C; Diehl V; Bohlen H
    Br J Haematol; 2000 Mar; 108(4):805-16. PubMed ID: 10792287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype.
    Gattorno M; Facchetti P; Ghiotto F; Vignola S; Buoncompagni A; Prigione I; Picco P; Pistoia V
    Clin Exp Immunol; 1997 Jul; 109(1):4-11. PubMed ID: 9218817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma.
    Cull G; Durrant L; Stainer C; Haynes A; Russell N
    Br J Haematol; 1999 Dec; 107(3):648-55. PubMed ID: 10583271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma.
    Hong S; Qian J; Li H; Yang J; Lu Y; Zheng Y; Yi Q
    Cancer Immunol Immunother; 2012 Apr; 61(4):561-71. PubMed ID: 22002243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.
    Hussain R; Kifayet A; Dojki M; Dockrell HM
    Immunology; 1999 Oct; 98(2):238-43. PubMed ID: 10540222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells.
    Rasmussen T; Hansson L; Osterborg A; Johnsen HE; Mellstedt H
    Blood; 2003 Jun; 101(11):4607-10. PubMed ID: 12576327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC).
    Abdalla AO; Kokhaei P; Hansson L; Mellstedt H; Osterborg A
    Ann Oncol; 2008 Jun; 19(6):1172-9. PubMed ID: 18272909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma.
    Osterborg A; Henriksson L; Mellstedt H
    Acta Oncol; 2000; 39(7):797-800. PubMed ID: 11145435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
    Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
    Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro priming of myeloma antigen-specific allogeneic donor T cells with idiotype pulsed dendritic cells.
    Kim SB; Baskar S; Kwak LW
    Leuk Lymphoma; 2003 Jul; 44(7):1201-8. PubMed ID: 12916873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW; Young HA; Pennington RW; Weeks SD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.
    Ahlers JD; Dunlop N; Alling DW; Nara PL; Berzofsky JA
    J Immunol; 1997 Apr; 158(8):3947-58. PubMed ID: 9103465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
    Reichardt VL; Milazzo C; Brugger W; Einsele H; Kanz L; Brossart P
    Haematologica; 2003 Oct; 88(10):1139-49. PubMed ID: 14555310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
    Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.